Ranked board
GHK-Cu sellers, and how far the copper peptide evidence goes
GHK-Cu is the rare case on this site where the evidence is genuinely encouraging: small randomized dermatology trials, in humans, measuring the thing the product is sold for. That makes it the clearest test of a seller's discipline, because there is a supportable claim available and most of these companies still make a bigger one.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
What gets on this board
Every published review whose dispensed list includes a product we have graded as GHK-Cu, topical or otherwise. Copper-containing cosmetics that do not name GHK-Cu are not on this board.
What decides the order
Companies we have a paid relationship with are listed first, and we say so here rather than marking individual rows. Within that group and within the rest, the order is the same measured one: how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Being a partner changes where a company sits, never what its numbers say.
What the grading found
3/12
Claims that match the trials
Across every one of these companies' GHK-Cu products that we have graded.
5/12
Name their pharmacy
A telehealth brand is almost never the pharmacy that fills the order.
1
Publish a readable certificate
Of every company reviewed on this site, not just those on this board.
The ranking
Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.
Only GHK-Cu products are counted here. A company's GLP-1 or NAD+ claims have no effect on where it lands on this board.
| Company | Claims vs. trials | Discloses | Visit |
|---|---|---|---|
Eden Checked August 2026 | 1/1100%
| Testing shown | Visit |
Andrew Meds Checked September 2026 | 1/1100%
| Nothing published | Visit |
NEUVÉ Health Checked September 2026 | 1/1100%
| Nothing published | Visit |
Alinwell Checked September 2026 | 0/10%
| Pharmacy namedTesting shownCertificate public | Visit |
The Edit Health Checked August 2026 | 0/10%
| Pharmacy namedTesting shown | Visit |
Auren Rx Checked August 2026 | 0/10%
| Pharmacy named | Visit |
telos rx Checked August 2026 | 0/10%
| Pharmacy named | Visit |
Transcend Checked August 2026 | 0/10%
| Pharmacy named | Visit |
AgelessRx Checked August 2026 | 0/10%
| Testing shown | Visit |
Believe Health Checked September 2026 | 0/10%
| Nothing published | Visit |
Goldspan Health Checked September 2026 | 0/10%
| Nothing published | Visit |
Longevixx Checked September 2026 | 0/10%
| Nothing published | Visit |
How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.
What this board does not measure
Whether it works
A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.
Clinical care
We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.
Price
Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.
Product quality
Only 1 of the companies reviewed here publish a certificate of analysis a customer can read, and a certificate is not on this board's ranking axis. Nothing here tells you what is in a vial.
Frequently asked questions
Why is GHK-Cu not affected by the compounding restriction?
The FDA PCAC restriction list covers BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, KPV, epitalon and semax — which is why no boards for those compounds are published here — and it does not include GHK-Cu. The companies on this board continue to dispense it as a prescription topical. If that changes, this board comes down rather than being quietly repopulated.
What does the strongest GHK-Cu claim look like?
A topical, cosmetic, appearance-of-skin claim, phrased at the size the dermatology trials actually reported. Where a row here is graded as reaching past the trials, it is almost always because a systemic or regenerative claim has been attached to a topical product — hair growth, wound healing, tissue repair — none of which those trials tested.
Nothing pinned
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.